Recursion Stock Market Invest

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Up 23.9% - Is It Still a Buy? Feb 17, 2025

Recursion Reschedules Q2 2024 Earnings Call to Early Morning Aug 8, 2024

Recursion Pharmaceuticals' Stock Slide Following Public Offering Announcement Jun 28, 2024